Risk Factors and Outcomes in Coronary Chronic Total Occlusion
Recruiting now
Conditions studied: Chronic Total Occlusion, Coronary Artery Disease
In brief
This study aims to assess the risk factors and evaluate the long-term outcomes of patients with coronary chronic total occlusion (CTO) treated with percutaneous coronary intervention or medical treatment.
Key facts
- Study ID
- NCT06137521
- Run by
- Ruijin Hospital
- People needed
- 3000
- Starts
- 2010-01-01
- Expected to finish
- 2027-03-01
- Last updated by the study team
- 2024-11-18
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Age ≥18 years; Patients with angina or silent ischemia and documented ischemia; Patients with CTO ≥ 3months
You may not qualify if…
- eGFR<15mL/(min·1.73m2); Chronic heart failure with NYHA grade ≥3; Had a history of coronary artery bypass grafting; Had received a percutaneous coronary intervention within the prior 3 months; Malignant tumor or immune system disorders; Pulmonary heart disease
Where it is running
- Ruijin Hospital, Shanghai Jiao Tong University School of Medicine — Shanghai, China (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.